SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-249636
Filing Date
2021-08-18
Accepted
2021-08-18 06:07:02
Documents
12
Period of Report
2021-08-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d199524d8k.htm   iXBRL 8-K 22127
  Complete submission text file 0001193125-21-249636.txt   147503

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA oric-20210817.xsd EX-101.SCH 2897
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE oric-20210817_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oric-20210817_pre.xml EX-101.PRE 11863
5 EXTRACTED XBRL INSTANCE DOCUMENT d199524d8k_htm.xml XML 3486
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39269 | Film No.: 211184951
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences